User: Guest  Login
Document type:
Clinical Trial; Clinical Trial, Phase I; Journal Article
Author(s):
Di Nicola, M; Carlo-Stella, C; Anichini, A; Mortarini, R; Guidetti, A; Tragni, G; Gallino, F; Del Vecchio, M; Ravagnani, F; Morelli, D; Chaplin, P; Arndtz, N; Sutter, G; Drexler, I; Parmiani, G; Cascinelli, N; Gianni, AM
Title:
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial.
Journal title abbreviation:
Hum Gene Ther
Year:
2003
Journal volume:
14
Journal issue:
14
Pages contribution:
1347-60
Language:
eng
Fulltext / DOI:
doi:10.1089/104303403322319426
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/14503969
Print-ISSN:
1043-0342
TUM Institution:
Institut für Virologie
 BibTeX